SCI PHARMTECH, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89 TWD | +0.56% |
|
+3.01% | -8.06% |
| Sales 2022 | 900M 27.62M 37.7M | Sales 2023 | 1.2B 36.96M 50.46M | Capitalization | 11.57B 355M 485M |
|---|---|---|---|---|---|
| Net income 2022 | 309M 9.48M 12.95M | Net income 2023 | 295M 9.06M 12.36M | EV / Sales 2022 | 10.6 x |
| Net Debt 2022 | 281M 8.63M 11.78M | Net Debt 2023 | 11.42M 351K 479K | EV / Sales 2023 | 9.62 x |
| P/E ratio 2022 |
30.2
x | P/E ratio 2023 |
36
x | Employees | 239 |
| Yield 2022 |
0.26% | Yield 2023 |
1.29% | Free-Float | 56.1% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.56% | ||
| 1 week | +3.01% | ||
| Current month | +0.68% | ||
| 1 month | +2.06% | ||
| 3 months | -5.92% | ||
| 6 months | -1.11% | ||
| Current year | -8.06% |
1 week
86.00
89.80
1 month
85.6090.00
Current year
85.60100.50
1 year
85.60116.44
3 years
59.11119.56
5 years
54.67119.56
10 years
41.04119.56
| Managers | Title | Age | Since |
|---|---|---|---|
Wei Chun Weng
CEO | Chief Executive Officer | - | 01-12-16 |
Wen Chen Yang
DFI | Director of Finance/CFO | - | 02-12-31 |
Wen Chih Chou
BRD | Director/Board Member | - | 10-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hsiang Li Chen
BRD | Director/Board Member | - | 01-12-16 |
Wei Chun Weng
CEO | Chief Executive Officer | - | 01-12-16 |
Wen Chih Chou
BRD | Director/Board Member | - | 10-08-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 89 | +0.56% | 178,999 |
| 24-04-25 | 88.5 | +0.80% | 162,161 |
| 24-04-24 | 87.8 | 0.00% | 85,129 |
| 24-04-23 | 87.8 | +1.50% | 97,399 |
| 24-04-22 | 86.5 | +0.12% | 236,005 |
End-of-day quote Taiwan S.E., April 25, 2024
More quotes
SCI Pharmtech, Inc. is a Taiwan-based company principally engaged in the processing, manufacture and sales of Active Pharmaceutical Ingredients (APIs). The Company's main products include APIs, API intermediates and special and precision chemicals. The Company distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others
Sector
Pharmaceuticals
Calendar
2024-05-09
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -8.06% | 326M | |
| +5.31% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| +18.82% | 2.38B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B |
- Stock Market
- Equities
- 4119 Stock
